For older adults with incidentally detected splenomegaly, a very large spleen volume predicts a substantial risk for ...

Please provide your email address to receive an email when new articles are posted on . The combination of pelabresib plus ruxolitinib significantly increased the proportion of patients with ...

Ojjaara helps patients with myelofibrosis by reducing spleen size, easing symptoms, and improving anemia to boost independence from blood transfusions. Ojjaara (momelotinib) is the first treatment of ...

Splenic vein thrombosis is a blockage in the splenic vein due to a blood clot. The splenic vein carries blood away from the spleen and parts of the stomach and pancreas. The spleen is an organ that ...

Accessory spleens are small nodules of splenic tissue that exist separate from the main organ, most often discovered incidentally during imaging or surgical procedures. Despite their typically benign ...

CK0804, a regulatory T cell therapy, received FDA orphan drug designation for myelofibrosis, supporting rare disease treatment development. Clinical study results showed significant reductions in ...